Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Karim Chamie
Based on 23 articles published since 2008
||||
Expertise Level
The expertise of Karim Chamie ranks in the Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    UCLA   Contact    
2018
  • Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. · David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. · Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. · Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. · Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. Electronic address: · Pubmed 29199023
  • Section of Urology, Department of Surgery, University of Chicago, Chicago, IL. Electronic address: · BCG Oncology, P.C., Phoenix, AZ. · Department of Urologic Oncology, Vanderbilt University, Nashville, TN. · Adult Pediatric Urology & Urogynecology, P.C., Omaha, NE. · Premier Urology Group, LLC, Edison, NJ. · Department of Urology, Wake Forest University, Winston-Salem, NC. · Alaska Urological Institute, Anchorage, AK. · University of Nebraska Medical Center, Omaha, NE. · Tri State Urologic Services, Cincinnati, OH. · Department of Urology, University of California Los Angeles, Los Angeles, CA. · Department of Urology, University of California San Diego, San Diego, CA. · Cold Genesys, Inc., Santa Ana, CA. · SciQuus Oncology, La Jolla, CA. · Section of Urology, Department of Surgery, University of Chicago, Chicago, IL. · Pubmed 28755959
  • David Geffen School of Medicine at the University of California Los Angeles, 300 Stein Plaza, Suite 348, Los Angeles, California, 90095, USA. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Riverside School of Medicine, University of California, Riverside, California, USA. · David Geffen School of Medicine at the University of California Los Angeles, 300 Stein Plaza, Suite 348, Los Angeles, California, 90095, USA. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Pubmed 30355350
  • Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Institute of Urologic Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA. · , 300 Stein Plaza, Suite 348, Los Angeles, CA, 90095, USA. · Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Institute of Urologic Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Division of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Division of Urology, Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA. · Pubmed 29752514
  • Department of Urology, David Geffen School of Medicine at University of California, 300 Stein Plaza, Suite 348, Los Angeles, CA, 90095, USA. · Institute of Urologic Oncology, University of California, Los Angeles, USA. · Department of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Department of Urology, David Geffen School of Medicine at University of California, 300 Stein Plaza, Suite 348, Los Angeles, CA, 90095, USA. · Institute of Urologic Oncology, University of California, Los Angeles, USA. · Pubmed 29299664
2017
  • Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA. Electronic address: · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA. · Division of Urology, Hahnemann University Hospital, Philadephia, PA. · Telormedix SA, Bioggio, Switzerland. · UroGen Pharma, Ra'anana, Israel. · The Urology Center of Colorado, Denver, CO. · BCG Oncology, Phoenix, AZ. · Carolina Urologic Research Center, Myrtle Beach, SC. · Pubmed 28341495
  • Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address: · Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Urology, Weill-Cornell Medical College, New York, NY, USA. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 28753760
  • The Division of Urology, The University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. · The Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, USA. · The Division of Urology, The University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. · Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Surgery, The University of Chicago, Chicago, IL, USA. · School of Public Health, Washington University, St. Louis, MO, USA. · Department of Urology, Case Western Reserve Medical Center, Cleveland, OH, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 28477210
  • Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California. · Accelerated Medical Diagnostics Incorporated, Berkeley, California. · Lawrence Livermore National Laboratory, Livermore, California. · The Jackson Laboratory, Sacramento, California. · Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, California. · Division of Hematology and Oncology, UCLA Medical Center, Los Angeles, California. · Department of Urology, UCLA Medical Center, Los Angeles, California. · Department of Urology, University of California Davis, Sacramento, California. · Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California. · VA Northern California Health Care System, Mather, California. · Pubmed 27903751
  • Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. Electronic address: · Division of Laboratory and Animal Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. · UroGen Pharma Ltd., Ra'anana, Israel. · Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA. · Pubmed 27720772
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; RAND Corporation, Santa Monica, CA; Department of Health Policy & Management, University of California Los Angeles School of Public Health, Los Angeles, CA. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; RAND Corporation, Santa Monica, CA. · RAND Corporation, Santa Monica, CA. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address: · Pubmed 27432529
2016
  • Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Urology, Emory University, Atlanta, GA; Department of Urology, Atlanta Veterans Affairs Medical Center, Decatur, GA. · Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA. · Department of Urology, Weill Cornell Medical College, New York, NY. Electronic address: · Pubmed 27372282
2015
  • Department of Urology, David Geffen School of Medicine, University of California Los Angeles, 300 Stein Plaza, 3rd Floor, Los Angeles, CA 90095, USA. · Pubmed 25558841
  • Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address: · Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA. · Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. · RAND Corporation, Santa Monica, CA. · Department of Urology, University of Minnesota, Minneapolis, MN. · Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; RAND Corporation, Santa Monica, CA; Department of Health Services, University of California Los Angeles, School of Public Health, Los Angeles, CA. · Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; RAND Corporation, Santa Monica, CA. · Pubmed 25443267
  • Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. · Pubmed 25339141
2014
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, 924 Westwood Boulevard, Suite 1000, Los Angeles, CA 90024, USA. · Pubmed 23979659
2013
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, California; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California. · Pubmed 23737352
2012
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90024, USA. · Pubmed 21823107
2011
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA. · Pubmed 21780079
2012
  • David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Pubmed 22529264
Probable:    University of California Davis   Contact    
2008
  • Department of Urology, University of California, Davis, Sacramento, CA, USA. · Pubmed 18410437
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 23 total) written by Karim Chamie about Urinary Bladder Neoplasms:

  • Durvalumab: an investigational anti-PD-L1 monoclonal antibody for the treatment of urothelial carcinoma. 2018
  • The Current Status and Future Role of the Phosphoinositide 3 Kinase/AKT Signaling Pathway in Urothelial Cancer: An Old Pathway in the New Immunotherapy Era. 2018
  • An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. 2018
  • Continuous saline bladder irrigation for two hours following transurethral resection of bladder tumors in patients with non-muscle invasive bladder cancer does not prevent recurrence or progression compared with intravesical Mitomycin-C. 2018
  • Overall survival in patients with residual disease after radical cystectomy and neoadjuvant chemotherapy. 2018
  • Trends in urinary diversion after radical cystectomy for urothelial carcinoma. 2018
  • A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer. 2017
  • Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer. 2017
  • Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer. 2017
  • Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice. 2017
Show List of Full Article Records
Google Searches

Learn more about Karim Chamie using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
UCLA
University of California Davis
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
UCLA
2018
  • Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. · David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. · Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. · Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. · Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Institute of Urologic Oncology, Department of Urology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA. Electronic address: · Pubmed 29199023
  • Section of Urology, Department of Surgery, University of Chicago, Chicago, IL. Electronic address: · BCG Oncology, P.C., Phoenix, AZ. · Department of Urologic Oncology, Vanderbilt University, Nashville, TN. · Adult Pediatric Urology & Urogynecology, P.C., Omaha, NE. · Premier Urology Group, LLC, Edison, NJ. · Department of Urology, Wake Forest University, Winston-Salem, NC. · Alaska Urological Institute, Anchorage, AK. · University of Nebraska Medical Center, Omaha, NE. · Tri State Urologic Services, Cincinnati, OH. · Department of Urology, University of California Los Angeles, Los Angeles, CA. · Department of Urology, University of California San Diego, San Diego, CA. · Cold Genesys, Inc., Santa Ana, CA. · SciQuus Oncology, La Jolla, CA. · Section of Urology, Department of Surgery, University of Chicago, Chicago, IL. · Pubmed 28755959
  • David Geffen School of Medicine at the University of California Los Angeles, 300 Stein Plaza, Suite 348, Los Angeles, California, 90095, USA. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Riverside School of Medicine, University of California, Riverside, California, USA. · David Geffen School of Medicine at the University of California Los Angeles, 300 Stein Plaza, Suite 348, Los Angeles, California, 90095, USA. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. · Pubmed 30355350
  • Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Institute of Urologic Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA. · , 300 Stein Plaza, Suite 348, Los Angeles, CA, 90095, USA. · Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Institute of Urologic Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Division of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Division of Urology, Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA. · Pubmed 29752514
  • Department of Urology, David Geffen School of Medicine at University of California, 300 Stein Plaza, Suite 348, Los Angeles, CA, 90095, USA. · Institute of Urologic Oncology, University of California, Los Angeles, USA. · Department of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA. · Department of Urology, David Geffen School of Medicine at University of California, 300 Stein Plaza, Suite 348, Los Angeles, CA, 90095, USA. · Institute of Urologic Oncology, University of California, Los Angeles, USA. · Pubmed 29299664
2017
  • Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA. Electronic address: · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, CA. · Division of Urology, Hahnemann University Hospital, Philadephia, PA. · Telormedix SA, Bioggio, Switzerland. · UroGen Pharma, Ra'anana, Israel. · The Urology Center of Colorado, Denver, CO. · BCG Oncology, Phoenix, AZ. · Carolina Urologic Research Center, Myrtle Beach, SC. · Pubmed 28341495
  • Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX, USA. Electronic address: · Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Urology, Weill-Cornell Medical College, New York, NY, USA. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 28753760
  • The Division of Urology, The University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. · The Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, USA. · The Division of Urology, The University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555, USA. · Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · Department of Surgery, The University of Chicago, Chicago, IL, USA. · School of Public Health, Washington University, St. Louis, MO, USA. · Department of Urology, Case Western Reserve Medical Center, Cleveland, OH, USA. · Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 28477210
  • Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California. · Accelerated Medical Diagnostics Incorporated, Berkeley, California. · Lawrence Livermore National Laboratory, Livermore, California. · The Jackson Laboratory, Sacramento, California. · Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, California. · Division of Hematology and Oncology, UCLA Medical Center, Los Angeles, California. · Department of Urology, UCLA Medical Center, Los Angeles, California. · Department of Urology, University of California Davis, Sacramento, California. · Department of Internal Medicine, Division of Hematology and Oncology and UC Davis Comprehensive Cancer Center, University of California Davis, Sacramento, California. · VA Northern California Health Care System, Mather, California. · Pubmed 27903751
  • Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. Electronic address: · Division of Laboratory and Animal Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. · UroGen Pharma Ltd., Ra'anana, Israel. · Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Radiology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. · Department of Urology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA. · Pubmed 27720772
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; RAND Corporation, Santa Monica, CA; Department of Health Policy & Management, University of California Los Angeles School of Public Health, Los Angeles, CA. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; RAND Corporation, Santa Monica, CA. · RAND Corporation, Santa Monica, CA. · Department of Urology, University of Minnesota, Minneapolis, MN. · Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address: · Pubmed 27432529
2016
  • Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Urology, Emory University, Atlanta, GA; Department of Urology, Atlanta Veterans Affairs Medical Center, Decatur, GA. · Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA. · Department of Urology, Weill Cornell Medical College, New York, NY. Electronic address: · Pubmed 27372282
2015
  • Department of Urology, David Geffen School of Medicine, University of California Los Angeles, 300 Stein Plaza, 3rd Floor, Los Angeles, CA 90095, USA. · Pubmed 25558841
  • Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. Electronic address: · Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA. · Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA. · RAND Corporation, Santa Monica, CA. · Department of Urology, University of Minnesota, Minneapolis, MN. · Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; RAND Corporation, Santa Monica, CA; Department of Health Services, University of California Los Angeles, School of Public Health, Los Angeles, CA. · Health Services Research Group, Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA; RAND Corporation, Santa Monica, CA. · Pubmed 25443267
  • Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. · Pubmed 25339141
2014
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine at UCLA, 924 Westwood Boulevard, Suite 1000, Los Angeles, CA 90024, USA. · Pubmed 23979659
2013
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine at University of California Los Angeles (UCLA), Los Angeles, California; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, California. · Pubmed 23737352
2012
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California 90024, USA. · Pubmed 21823107
2011
  • Department of Urology, Health Services Research Group, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA. · Pubmed 21780079
2012
  • David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Pubmed 22529264
Unspecified
2018
  • Department of Urology. · Institute of Urologic Oncology. · Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA. · Pubmed 29416316
University of California Davis
2008
  • Department of Urology, University of California, Davis, Sacramento, CA, USA. · Pubmed 18410437
Yearly article counts 066131122001
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.